Navigation Links
Synthetic Biology - Global Strategic Business Report 2015-2020: Profiles of 51 Companies Including Many Key and Niche Players
Date:4/8/2015

DUBLIN, Apr. 08, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/247v7d/synthetic_biology) has announced the addition of the "Synthetic Biology - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Product Segments: Enabled Products, and Others. The report also analyzes the market by the following Application Areas: Energy and Chemicals, Biotechnology and Pharmaceuticals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report profiles 51 companies including many key and niche players such as:

Players Focused on Synthetic Biology Applications

  • Amyris, Inc. (US)
  • BP PLC. (UK)
  • Chromatin Inc. (US)
  • Evolva SA (Switzerland)
  • Gevo, Inc. (US)
  • Joule Unlimited, Inc. (US)
  • Metabolix (US)
  • MorphoSys AG (Germany)
  • Sapphire Energy, Inc. (US)
  • Solazyme, Inc. (US)
  • Synthetic Biologics, Inc. (US)
  • Synthetic Genomics, Inc. (US)

Players Focused on Gene Synthesis and Tools

  • 454 Life Sciences (US)
  • Agilent Technologies Inc. (US)
  • ATG Biosynthetics GmbH (Germany)
  • DNA2.0 (US)
  • Epoch Life Science, Inc. (US)
  • Gen9, Inc. (US)
  • GenScript USA, Inc. (US)
  • Gingko Bioworks, Inc. (US)
  • Intrexon Corporation (US)
  • LC Sciences LLC (US)
  • Life Technologies Corp. (US)
  • OPXBIO, Inc. (US)
  • OriGene Technologies, Inc. (US)
  • Sangamo BioSciences, Inc. (US)
  • Verdezyne, Inc. (US

Key Topics Covered:

1. OUTLOOK

2. INDUSTRY OVERVIEW

3. MARKET TRENDS, DRIVERS, AND ISSUES

4. KEY RESEARCH FINDINGS ON SYNTHETIC BIOLOGY

5. SYNTHETIC BIOLOGY - AN OVERVIEW

6. PRODUCT INNOVATIONS/INTRODUCTIONS

7. RECENT INDUSTRY ACTIVITY

8. FOCUS ON SELECT PLAYERS

9. GLOBAL MARKET PERSPECTIVE 

Total Companies Profiled: 51 (including Divisions/Subsidiaries (52)

  • The United States (41)
  • Canada (1)
  • Europe (8)
  • France (1)
  • Germany (3)
  • The United Kingdom (1)
  • Spain (1)
  • Rest of Europe (2)
  • Asia-Pacific (Excluding Japan) (2)

For more information visit http://www.researchandmarkets.com/research/247v7d/synthetic_biology

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Synthetic Biologics SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015
2. Synthetic Biologics Reports Year End 2014 Financial Results and Operational Highlights
3. Synthetic Biologics to Present at the 27th Annual ROTH Conference
4. Expanding Application Areas to Drive Growth in the Global Synthetic Biology Market, According to a New Report by Global Industry Analysts, Inc.
5. Kuros Announces Grant of US Patent for its Synthetic Hydrogel Technology
6. Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection
7. Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets
8. Bioadhesives Poised to Replace Synthetic Solutions, Finds Frost & Sullivan
9. Intrexon Announces the Appointment of Peter Emtage, Ph.D., as Vice President, Synthetic Immunology
10. Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018
11. Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... 25, 2020 , ... Lumeda Inc. (“Lumeda”), a ... the company has entered a license agreement with Roswell Park Comprehensive Cancer Center ... rights to Roswell Park intellectual property surrounding a novel medical device and method ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... indoor environments, announced today that Derek Fournier has been appointed CEO and President. ... the Board, effective immediately. , “DeCurtis Corporation has been on an incredible ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical company ... filed an Investigational New Drug application (IND) with the U.S. Food & Drug ... candidate NBTX-001 in patients with panic disorder (PD). , "Adding a PD trial ...
(Date:6/11/2020)... ... , ... PathSensors Inc., a Baltimore biotechnology company, announced today ... funded by the National Institute of Food and Agriculture (NIFA) entitled “Food Safety ... was to engineer and develop a field-deployable instrument for portable pathogen and toxin ...
Breaking Biology Technology:
(Date:7/18/2020)... ... July 16, 2020 , ... A study ... the Invictus Medical Neoasis™ active noise control device to attenuate typical noises in ... Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other bedside ...
(Date:7/2/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... company, presented its phase 1a findings of Neihulizumab, a biologic for the treatment ... in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
Breaking Biology News(10 mins):